| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |